海正藥業(600267.SH)再次拍賣成交君悦大廈15套公寓
格隆匯11月21日丨海正藥業(600267.SH)公佈,為盤活閒置資產,提高資產運營效率,公司以評估值為依據通過產權交易機構公開掛牌出售位於北京、上海、杭州、椒江四處的閒置房產。
公司委託台交所和浙江城鄉拍賣有限公司共同組織實施椒江君悦大廈27套公寓拍賣事宜。2019年5月15日上午,椒江君悦大廈27套公寓在台州市公共資源交易中心三樓一號開標室公開拍賣,拍賣成交7套公寓。後續,公司再次向台交所提交了台州市椒江區君悦大廈20套公寓掛牌申請,相關房產再次委託台交所通過拍賣方式轉讓。
2019年11月21日上午9:30在台州市府大道777號台州市公共資源交易中心三樓一號開標室,公司委託台交所和浙江城鄉拍賣有限公司共同組織實施再次公開拍賣君悦大廈20套公寓,最終拍賣成交15套公寓。
台州市椒江區君悦大廈剩餘5套公寓將根據市場情況擇機進行再次掛牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.